Literature DB >> 16394047

Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy.

Anthony T Dann1, Anna P Kenyon, Anthony S Wierzbicki, Paul T Seed, Andrew H Shennan, Rachel M Tribe.   

Abstract

OBJECTIVE: Intrahepatic cholestasis of pregnancy is associated with dyslipidemia, but the gestational lipid profile in relation to clinical diagnosis of the disease is unknown. The aim of this study was to undertake a detailed analysis of plasma lipids in women presenting with intrahepatic cholestasis of pregnancy and pruritus gravidarum.
METHODS: Plasma lipid concentrations were assessed in nonfasting blood samples from 63 women with intrahepatic cholestasis of pregnancy (n = 54, recruited at the time of diagnosis, and n = 9, who later developed the disease), 43 women with pruritus gravidarum, and 26 healthy pregnant controls during pregnancy and at 4-6 weeks postpartum.
RESULTS: Intrahepatic cholestasis of pregnancy was associated with an abnormal lipid profile. Low-density lipoprotein (LDL) cholesterol, apolipoprotein B-100, and total cholesterol concentrations were significantly raised during pregnancy in women with intrahepatic cholestasis of pregnancy compared with pruritus gravidarum and controls, and LDL-cholesterol was raised before clinical diagnosis. High-density lipoprotein cholesterol was lower in women with intrahepatic cholestasis of pregnancy compared with the pruritus gravidarum group. Ursodeoxycholic acid did not alter plasma lipid concentrations.
CONCLUSION: Intrahepatic cholestasis is associated with dyslipidemia, which may contribute to the pathogenesis of the disease. The elevation of LDL cholesterol and reduction of high-density lipoprotein cholesterol before clinical diagnosis may prove to be a useful biomarker for the early identification of intrahepatic cholestasis of pregnancy and differentiation from pruritus gravidarum. LEVEL OF EVIDENCE: II-2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16394047     DOI: 10.1097/01.AOG.0000189096.94874.9c

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  21 in total

Review 1.  Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems.

Authors:  Jurate Kondrackiene; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 2.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

3.  Maternal Serum Lipid, Estradiol, and Progesterone Levels in Pregnancy, and the Impact of Placental and Hepatic Pathologies.

Authors:  U Pecks; W Rath; N Kleine-Eggebrecht; N Maass; F Voigt; T W Goecke; M G Mohaupt; G Escher
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-07       Impact factor: 2.915

4.  Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis.

Authors:  A P Kenyon; R M Tribe; C Nelson-Piercy; J C Girling; C Williamson; P T Seed; S Vaughan-Jones; A H Shennan
Journal:  Obstet Med       Date:  2010-03-04

5.  Good pregnancy outcome despite intrahepatic cholestasis.

Authors:  Kaisa Turunen; Markku Sumanen; Riitta-Liisa Haukilahti; Pertti Kirkinen; Kari Mattila
Journal:  Scand J Prim Health Care       Date:  2010-06       Impact factor: 2.581

6.  GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements.

Authors:  Peter H Dixon; Adam P Levine; Inês Cebola; Daniel P Gale; Catherine Williamson; Melanie M Y Chan; Aliya S Amin; Anshul Aich; Monika Mozere; Hannah Maude; Alice L Mitchell; Jun Zhang; Jenny Chambers; Argyro Syngelaki; Jennifer Donnelly; Sharon Cooley; Michael Geary; Kypros Nicolaides; Malin Thorsell; William M Hague; Maria Cecilia Estiu; Hanns-Ulrich Marschall
Journal:  Nat Commun       Date:  2022-08-17       Impact factor: 17.694

7.  Maternal cholestasis during pregnancy programs metabolic disease in offspring.

Authors:  Georgia Papacleovoulou; Shadi Abu-Hayyeh; Evanthia Nikolopoulou; Oscar Briz; Bryn M Owen; Vanya Nikolova; Caroline Ovadia; Xiao Huang; Marja Vaarasmaki; Marc Baumann; Eugene Jansen; Christiane Albrecht; Marjo-Riitta Jarvelin; Jose J G Marin; A S Knisely; Catherine Williamson
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808

8.  Rosiglitazone alleviates intrahepatic cholestasis induced by α-naphthylisothiocyanate in mice: The role of circulating 15-deoxy-Δ12,14 -PGJ2 and Nogo.

Authors:  Shuang Zhang; Miao Yu; Fangling Guo; Xiaoxiao Yang; Yuanli Chen; Chuanrui Ma; Qi Li; Zhuo Wei; Xiaoju Li; Hua Wang; Huaqing Hu; Yujue Zhang; Derun Kong; Qing Robert Miao; Wenquan Hu; David P Hajjar; Yan Zhu; Jihong Han; Yajun Duan
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

Review 9.  Pregnancy-associated liver disorders.

Authors:  Iryna S Hepburn; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-02-07       Impact factor: 3.199

10.  Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype.

Authors:  Shadi Abu-Hayyeh; Georgia Papacleovoulou; Anita Lövgren-Sandblom; Mehreen Tahir; Olayiwola Oduwole; Nurul Akmal Jamaludin; Sabiha Ravat; Vanya Nikolova; Jenny Chambers; Clare Selden; Myrddin Rees; Hanns-Ulrich Marschall; Malcolm G Parker; Catherine Williamson
Journal:  Hepatology       Date:  2013-01-08       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.